Spread the loveThe annual NVIDIA GTC conference, held in San Jose from March 16 to 19, 2026, has once again positioned the company at the forefront of artificial intelligence (AI) technology. This ...

Lightbits Labs Ltd. today is introducing a new architecture aimed at addressing one of the most stubborn bottlenecks in large-scale artificial intelligence inference: the growing mismatch between the ...

Nvidia's upcoming GTC conference will reveal CEO Jensen Huang's AI hardware, software, and partnership plans. Investors ...

Researchers present NorthPole – a brain-inspired chip architecture that blends computation with memory to process data efficiently at low-energy costs. Since its inception, computing has been ...

Nvidia is reportedly developing a specialized processor aimed at accelerating AI inference, a move that could reshape how ...

SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform.